Yeasts as probiotics: Mechanisms, outcomes, and future potential

Sen, Swastik; Mansell, Thomas J.

doi:10.1016/j.fgb.2020.103333

Cited by 106 publications

(57 citation statements)

References 101 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Corroborating the ulterior finding, and according to Sen and Mansell [45], S. boulardii and S. cerevisiae are genetically similar, each containing 16 chromosomes with greater than 99% relatedness [46]. Some of the important differences include those in the genes expressing some flocculation proteins, which contribute to a different adhesion profile of S. boulardii when compared to S. cerevisiae [47].…”

Section: Yeasts As Probiotics In Alcoholic Drinksmentioning

confidence: 87%

“…Corroborating the ulterior finding, and according to Sen and Mansell [45], S. boulardii and S. cerevisiae are genetically similar, each containing 16 chromosomes with greater than 99% relatedness articles on PubMed: using the keywords "probiotic" and "yeast", from 1995 to 2020. Data retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=probiotic+yeast (B)-Number of articles on PubMed: using the keywords "probiotic" and "yeast" and "wine", data retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=probiotic+yeast+wine.…”

Section: Yeasts As Probiotics In Alcoholic Drinksmentioning

confidence: 98%

See 1 more Smart Citation

Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and Prebiotics

2020

View full text Add to dashboard Cite

Probiotics and prebiotics are microbiota-management instruments for improving human health once they may be beneficial for maintaining a healthy community of gut microbiota and bowel function. Probiotic’s main target is the gut, via the gastrointestinal tract, although direct application to other body zones such as the vaginal tract, the oral cavity, and skin have been studied. The major source of probiotics is fermented dairy products, however, currently, there is a need for novel and non-dairy probiotics, due to the increasing number of lactose-intolerant persons in the world population, tied with the adverse effect of cholesterol contained in fermented dairy foods as well as the increasing number of strict vegetarians. In this review, we describe gut-derived effects in humans of possible microorganisms isolated from wine, such as Saccharomyces and non-Saccharomyces yeasts and bacteria, and other non-dairy fermented beverages. Those microorganisms can be grown and consumed as recommended probiotics, moreover, wine, and other beverages may also be a source of prebiotics such as polyphenols.

show abstract

Section: Yeasts As Probiotics In Alcoholic Drinksmentioning

confidence: 87%

“…Corroborating the ulterior finding, and according to Sen and Mansell [45], S. boulardii and S. cerevisiae are genetically similar, each containing 16 chromosomes with greater than 99% relatedness articles on PubMed: using the keywords "probiotic" and "yeast", from 1995 to 2020. Data retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=probiotic+yeast (B)-Number of articles on PubMed: using the keywords "probiotic" and "yeast" and "wine", data retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=probiotic+yeast+wine.…”

Section: Yeasts As Probiotics In Alcoholic Drinksmentioning

confidence: 98%

Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and Prebiotics

2020

View full text Add to dashboard Cite

show abstract

“…S. boulardii CNCM I-745 was the first strain that has been studied for use as probiotic in human medicine, and it is one of the recommended probiotics for the prevention and treatment of antibiotic-related diarrhea, including Clostridium difficile-associated diarrhea (Czerucka and Rampal, 2019). Additionally, preclinical studies have shown that this Saccharomyces strain presents a beneficial effect against many gastrointestinal pathogens such as Salmonella typhimurium, Shigella flexneri, Escherichia coli (enteropathogenic and enterohaemorrhagic strains), Vibrio cholerae, Rotavirus, and C. albicans (Czerucka and Rampal, 2019;Sen and Mansell, 2020).…”

Section: Yeast-based Probiotics As a Novel Therapeutic Approachmentioning

confidence: 99%

Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections

et al. 2020

View full text Add to dashboard Cite

Vaginal infections affect 70% of women during their lifetimes and account for millions of annual doctors' visits. These infections are predominantly represented by vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV). Although standard antimicrobial agents remain the major strategy for the prevention and treatment of vaginal infections, both VVC and BV are difficult to treat due to high rates of resistance and recurrence, high probability of complications, and negative effects on the vaginal microbiota. This review focuses on a new approach of yeast-based probiotics for the prevention and/or treatment of these common vaginal infections.

show abstract

“…This study shows how yeast can be an integral part of human microbiome as probiotics. Saccharomyces boulardii is commonly used to reduce GI tract ailments, since is it well characterized probiotic yeast (Sen and Mansell 2020 ). Supplementing probiotics have shown to be useful in several gastrointestinal diseases, such as irritable bowel syndrome, inflammatory bowel disease, improving the H. pylori eradication rates, preventing or decreasing antibiotic-associated diarrhea, and lowering the taste disturbance incidences.…”

Section: Combating H Pylori Infectionmentioning

confidence: 99%

Helicobacter pylori: Perturbation and restoration of gut microbiome

2020

View full text Add to dashboard Cite

Alternate remedies with natural products provides unlimited opportunities for new drug development. These can be either as pure compounds or as standardized set of compounds. The phytochemicals and secondary metabolites are in great demand for screening bioactive compounds and plays an important role towards drug development. Natural products have many advantages over to synthetic chemical drugs. Helicobacter pylori (H. pylori) a Gram-negative bacteria has been classified as Class I carcinogen by World Health Organization in 1994. Current treatment regimens for H. pylori is 'triple therapy' administrated for two weeks which includes a combination of two antibiotics like Amoxicillin and Clarithromycin and a proton pump inhibitor (PPI) like Lansoprazole, and for 'quadruple therapy' in addition to antibiotics and a PPI, Bismuth is used. Antibiotic resistance can be named as the main factor for failure of treatment of H. pylori infection. The need of the hour is to develop a herbal remedy that could combat the growth of H. pylori. Probiotics can also be used as 'feasible' tool for H. pylori infection management. Present review is an attempt to briefly discuss about the pathogenicity, genetic predisposition, perturbation of gut microbiota due to antibiotic treatment and restoration of healthy gut microbiota with phytochemicals and probiotics.

show abstract

Yeasts as probiotics: Mechanisms, outcomes, and future potential

Cited by 106 publications

References 101 publications

Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and Prebiotics

Wine and Non-Dairy Fermented Beverages: A Novel Source of Pro- and Prebiotics

Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections

Helicobacter pylori: Perturbation and restoration of gut microbiome

Contact Info

Product

Resources

About